Article Details

After Surging 16.22% During Past Week, Is Kintara Therapeutics, Inc. (NASDAQ:KTRA) Still A Buy?

Retrieved on: 2021-03-13 14:00:57

Tags for this article:

Click the tags to see associated articles and topics

After Surging 16.22% During Past Week, Is Kintara Therapeutics, Inc. (NASDAQ:KTRA) Still A Buy?. View article details on hiswai:

Excerpt

The next major institution holding the largest number of shares is Renaissance Technologies, LLC with 40.73 Thousand shares, or about 0.13% of ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up